• Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
      • Investors
      • Grants
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
  • Research Oncology Solutions
    • Drug Discovery/ Drug Repurposing/Clinical Translations
  • Media
    • Awards & Recognitions
    • Newsroom
    • Blog
    • Youtube
  • Gallery
    • People
    • Labs
      • Main Lab
      • Tissue Culture
      • Animal House
      • Incubator
    • Instrumentation
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers

Fortune India recognises Mestastop as one of India’s “Transformative R&D”s.

Home » newsrooms_mestastop » Fortune India recognises Mestastop as one of India’s “Transformative R&D”s.

Fortune India recognises Mestastop as one of India’s “Transformative R&D”s.

Posted on December 29, 2023December 29, 2023 by Mestastop

Recent Posts

  • Mestastop gets a 2.66 Cr grant from BIRAC for extending its proprietary drug discovery models into oral and breast cancer
  • Mestastop Solutions and Ectica Technologies participate in the Swiss Biotech Days 2024
  • Mestastop Solutions and Vipragen Biosciences signs a Memorandum of Understanding.
  • Mestastop Solutions and St Johns Research Institute signed a Research Agreement.
  • Mestastop Solutions and Bangalore BioInnovation Centre collaborates to develop drug discovery models to combat cancer metastasis

Recent Comments

No comments to show.

Archives

  • November 2024
  • April 2024
  • December 2023

Categories

  • Uncategorized
  • Home
  • About Us
  • Technology
  • Research Oncology Solutions
  • Media
  • Gallery
  • Contact Us
  • Careers
  • Privacy Policy
Linkedin Twitter Youtube